Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Schiffman

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|January 8, 2016
Tick-borne Disease Prevention: Still No Silver BulletElizabeth K Schiffman, David F Neitzel, Ruth Lynfield
Journal of Clinical Gastroenterology|September 19, 2000
A pancreatic intraductal papillary mucinous tumor causing recurrent acute pancreatitis at the onset of menstrual periodsV Tikhomirov, S Tikhomirova, S Sieber, et al.
Journal of Mammary Gland Biology and Neoplasia|March 8, 2000
Immunotherapeutic approaches for the treatment of breast cancerK L Knutson, K Schiffman, K Rinn, et al.
The Journal of Allergy and Clinical Immunology|July 10, 1999
Antigen-specific recall urticaria to a peptide-based vaccineK Rinn, K Schiffman, H O Otero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcomeJ L Lee, T Gooley, W Bensinger, et al.
Breast Cancer Research and Treatment|November 10, 2000
Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancerM L Disis, K L Knutson, K Schiffman, et al.
Critical Reviews in Immunology|October 20, 2001
Clinical translation of peptide-based vaccine trials: the HER-2/neu modelM L Disis, K L Knutson, D G McNeel, et al.
Zoonoses and Public Health|May 29, 2024
Epidemiologic and tick exposure characteristics among people with reported Lyme disease - Minnesota, 2011-2019Austin R Earley, Elizabeth K Schiffman, Karen K Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunizationM L Disis, K Schiffman, T A Gooley, et al.
Endocrine-Related Cancer|March 27, 2002
Vaccination against the HER-2/neu oncogenic proteinH Bernhard, L Salazar, K Schiffman, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|January 8, 2016
Tick-borne Disease Prevention: Still No Silver BulletElizabeth K Schiffman, David F Neitzel, Ruth Lynfield
Journal of Clinical Gastroenterology|September 19, 2000
A pancreatic intraductal papillary mucinous tumor causing recurrent acute pancreatitis at the onset of menstrual periodsV Tikhomirov, S Tikhomirova, S Sieber, et al.
Journal of Mammary Gland Biology and Neoplasia|March 8, 2000
Immunotherapeutic approaches for the treatment of breast cancerK L Knutson, K Schiffman, K Rinn, et al.
The Journal of Allergy and Clinical Immunology|July 10, 1999
Antigen-specific recall urticaria to a peptide-based vaccineK Rinn, K Schiffman, H O Otero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcomeJ L Lee, T Gooley, W Bensinger, et al.
Breast Cancer Research and Treatment|November 10, 2000
Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancerM L Disis, K L Knutson, K Schiffman, et al.
Critical Reviews in Immunology|October 20, 2001
Clinical translation of peptide-based vaccine trials: the HER-2/neu modelM L Disis, K L Knutson, D G McNeel, et al.
Zoonoses and Public Health|May 29, 2024
Epidemiologic and tick exposure characteristics among people with reported Lyme disease - Minnesota, 2011-2019Austin R Earley, Elizabeth K Schiffman, Karen K Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunizationM L Disis, K Schiffman, T A Gooley, et al.
Endocrine-Related Cancer|March 27, 2002
Vaccination against the HER-2/neu oncogenic proteinH Bernhard, L Salazar, K Schiffman, et al.
Pageof 5